Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rangering i aksjer #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Aksjekurs
$29.86
Sist synkronisert: 2026-08-19
Markedsverdi
$2.48B
Endring (1 dag)
4.92%
Endring (1 år)
502.82%
Land
TW
Handel Lin BioScience, Inc. (6696)

Kategori

Aksjeprishistorikk for Lin BioScience, Inc. (6696)
Høyeste sluttskurs: $26.88 den 2026-08-01

Laveste sluttskurs: $1.30 den 2018-10-01
Aksjeprishistorikk for Lin BioScience, Inc. fra 2018 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -3.77%
2025 202.95%
2024 13.59%
2023 -31.65%
2022 -22.82%
2021 101.12%
2020 278.57%
2019 -21.27%
2018 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$543.30 39.64%
US
$1.05K 47.66%
NL
$122.63 -12.65%
AU
$144.26 474.74%
US
$761.61 6.68%
CH